Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

June Health vs No BS RX

June Health
Graded #287

Lower grade

vs+19.8
No BS RX
Graded #26

Higher grade

The verdict

No BS RX takes it — 82.8/100 to 63/100.

No BS RX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Twenty-four prices on one public page, four dispensing pharmacies named with street addresses, and a no-intro-rate promise the arithmetic actually supports.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueNo BS RX +31
61
92
Dose & formulationNo BS RX +15
75
90
Clinical oversightNo BS RX +13
59
72
Labs & monitoringNo BS RX +17
51
68
FulfillmentNo BS RX +20
74
94
Contract termsNo BS RX +19
55
74
June Health · left barNo BS RX · right bar

The numbers

MetricJune HealthNo BS RX
WeighScore63/10082.8/100
GradeCB−
Scorecard rank#287#26
Semaglutide$179/mo (starting dose, compounded)$179/mo month-to-month (a separate low-dose program is $140)
Tirzepatide$179/mo (starting dose, compounded)$249/mo month-to-month (a separate low-dose program is $140)
CoverageCoverage not publishedNot publicly listed
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesYes
June Health

Graded #287 · C

Strengths

  • Offers both injectable and oral compounded semaglutide and tirzepatide
  • Semaglutide starts at $179/mo (injectable) or $187/mo (tablets) — tirzepatide from $179/mo (injectable)
  • Full per-dose price list published on-site with no signup required to view it
  • Provider consult ('licensed clinician evaluation') is bundled into the displayed price
  • Free discreet shipping advertised with 2-3 day delivery

Where it loses points

  • No accessible Terms of Service or Privacy Policy — footer links go nowhere and standard URL guesses 404
  • No LegitScript seal or other pharmacy-verification badge found anywhere on the site
  • Legal entity, prescribing medical group, and compounding pharmacy partner are not named
  • Domain was registered in May 2026 — a brand-new storefront with no independent reviews found
  • Also sells 'MR-3' (retatrutide), a GLP-1/GIP/glucagon agonist with no FDA approval for any use
No BS RX

Graded #26 · B−

Strengths

  • Names four dispensing pharmacies with street addresses and telephone numbers — Red Rock Compounding Pharmacy, Health Warehouse, Precision Medicine and Triad Rx
  • "No Fake Intro Rate — the price on the page is the ongoing program price" is a named commitment, and the $140 in its hero really is a month-to-month rate on a real product
  • Every program row prints "503A pharmacy fulfillment" and "No dose-based price changes" on the table itself
  • Six programs across four terms are published with no intake and no account
  • A sleep program is priced on the same page, including a diagnostic ring study at $33/mo

Where it loses points

  • The same $409 twelve-week block appears under three different monthly rates — an $11 saving against one and a $128 saving against another, styled identically
  • The low-dose programs stop at twelve weeks; only the standard programs carry 24- and 52-week rungs
  • The Terms name four pharmacies and no operating company
  • State availability is not published, and there is no FDA-approved brand lane

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 544 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard